TARIS Bio Information

TARIS Biomedical is building a world-class specialty pharmaceutical company focused on providing powerful new treatments to the millions of patients suffering from bladder diseases. We are advancing therapies for debilitating conditions, including bladder cancer and overactive bladder, enabled by continuous local dosing where it is needed.

Website	http://www.tarisbio.com
Revenue	$12.7 million
Employees	25 (2 on RocketReach)
Founded	2008
Address	113 Hartwell Ave, Lexington, Massachusetts 02421, US
Phone	+1 781-676-7750
Technologies	JavaScript , HTML , PHP +28 more (view full list)
Industry	Pharmaceuticals, Manufacturing General, Urology, Manufacturing, Continuous Local Dosing, Bladder Diseases, Oncology, Voiding Dysfunction
Web Rank	15 Million
Keywords	Patient Care, Treatment Options, Improving Patient Outcomes, Medical Innovation, Disease Management, Health Solutions, Pharmaceutical Research, Biomedical Research, Drug Development, Advanced Therapies, Specialty Pharmaceuticals, Innovative Medicines, Clinical Trials, Health Technology, New Drug Applications, Pharmaceutical Development, Fda Approval
Competitors	Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences +41 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 873 Companies
NAICS	NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 541711 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies